Ocean College, Zhejiang University, Hangzhou 310058, China.
Department of Applied Chemistry, Zhejiang Gongshang University, Hangzhou 310012, China.
Mar Drugs. 2017 Nov 10;15(11):354. doi: 10.3390/md15110354.
Nowadays, various drugs on the market are becoming more and more resistant to numerous diseases, thus declining their efficacy for treatment purposes in human beings. Antibiotic resistance is one among the top listed threat around the world which eventually urged the discovery of new potent drugs followed by an increase in the number of deaths caused by cancer due to chemotherapy resistance as well. Accordingly, marine cyanobacteria, being the oldest prokaryotic microorganisms belonging to a monophyletic group, have proven themselves as being able to generate pharmaceutically important natural products. They have long been known to produce distinct and structurally complex secondary metabolites including peptides, polyketides, alkaloids, lipids, and terpenes with potent biological properties and applications. As such, this review will focus on recently published novel compounds isolated from marine cyanobacteria along with their potential bioactivities such as antibacterial, antifungal, anticancer, anti-tuberculosis, immunosuppressive and anti-inflammatory capacities. Moreover, various structural classes, as well as their technological uses will also be discussed.
如今,市场上的各种药物对许多疾病的耐药性越来越强,因此降低了它们在人类治疗中的疗效。抗生素耐药性是世界上名列前茅的威胁之一,这最终促使人们发现了新的有效药物,同时由于化疗耐药性,癌症导致的死亡人数也有所增加。因此,海洋蓝细菌作为最古老的原核微生物,属于单系群,已被证明能够产生具有药用价值的天然产物。它们长期以来一直以产生独特且结构复杂的次生代谢产物而闻名,包括具有强大生物学特性和应用的肽、聚酮、生物碱、脂质和萜类化合物。因此,本综述将重点介绍最近从海洋蓝细菌中分离出的新型化合物及其潜在的生物活性,如抗菌、抗真菌、抗癌、抗结核、免疫抑制和抗炎作用。此外,还将讨论各种结构类别及其技术用途。